Isthmus Partners’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-14,829
| Closed | -$1.1M | – | 168 |
|
|
2022
Q4 | $1.1M | Sell |
14,829
-15,948
| -52% | -$1.18M | 0.17% | 109 |
|
|
2022
Q3 | $1.83M | Buy |
30,777
+1,650
| +6% | +$98.3K | 0.32% | 65 |
|
|
2022
Q2 | $1.64M | Buy |
29,127
+786
| +3% | +$44.1K | 0.31% | 76 |
|
|
2022
Q1 | $2.09M | Buy |
28,341
+1,248
| +5% | +$92.1K | 0.34% | 60 |
|
|
2021
Q4 | $1.96M | Buy |
27,093
+369
| +1% | +$26.6K | 0.33% | 70 |
|
|
2021
Q3 | $2.05M | Sell |
26,724
-131
| -0.5% | -$10K | 0.37% | 61 |
|
|
2021
Q2 | $2.08M | Buy |
26,855
+73
| +0.3% | +$5.66K | 0.37% | 60 |
|
|
2021
Q1 | $1.65M | Sell |
26,782
-292
| -1% | -$18K | 0.3% | 80 |
|
|
2020
Q4 | $1.77M | Sell |
27,074
-695
| -3% | -$45.3K | 0.36% | 53 |
|
|
2020
Q3 | $1.38M | Sell |
27,769
-111
| -0.4% | -$5.5K | 0.32% | 57 |
|
|
2020
Q2 | $1.33M | Sell |
27,880
-1,189
| -4% | -$56.7K | 0.33% | 56 |
|
|
2020
Q1 | $1.24M | Sell |
29,069
-424
| -1% | -$18K | 0.38% | 51 |
|
|
2019
Q4 | $1.74M | Sell |
29,493
-170
| -0.6% | -$10K | 0.4% | 50 |
|
|
2019
Q3 | $1.52M | Buy |
29,663
+1,030
| +4% | +$52.6K | 0.36% | 51 |
|
|
2019
Q2 | $1.21M | Buy |
+28,633
| New | +$1.21M | 0.29% | 65 |
|
|
2019
Q1 | – | Sell |
-27,630
| Closed | -$1.2M | – | 154 |
|
|
2018
Q4 | $1.2M | Buy |
27,630
+2,244
| +9% | +$97.1K | 0.36% | 58 |
|
|
2018
Q3 | $1.44M | Sell |
25,386
-1,093
| -4% | -$62K | 0.36% | 50 |
|
|
2018
Q2 | $1.34M | Sell |
26,479
-349
| -1% | -$17.6K | 0.35% | 51 |
|
|
2018
Q1 | $1.34M | Sell |
26,828
-1,278
| -5% | -$63.7K | 0.36% | 46 |
|
|
2017
Q4 | $1.16M | Sell |
28,106
-436
| -2% | -$17.9K | 0.31% | 52 |
|
|
2017
Q3 | $848K | Buy |
28,542
+262
| +0.9% | +$7.78K | 0.24% | 78 |
|
|
2017
Q2 | $937K | Sell |
28,280
-825
| -3% | -$27.3K | 0.27% | 62 |
|
|
2017
Q1 | $862K | Buy |
29,105
+11,585
| +66% | +$343K | 0.25% | 69 |
|
|
2016
Q4 | $435K | Buy |
+17,520
| New | +$435K | 0.13% | 107 |
|